Author

Aoife O’Shaughnessy-Kirwan

Observed names: A. O'Shaughnessy Kirwan, Aoife O'Shaughnessy-Kirwan, O'Shaughnessy-Kirwan, Aoife, O’Shaughnessy-Kirwan, A, O’Shaughnessy-Kirwan, Aoife

Institution: St. James's Hospital

Observed institutions: SingHealth, National University of Singapore, Wellcome/MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge University Hospitals NHS Foundation Trust, SingHealth Duke-NUS Academic Medical Centre, Duke-NUS Medical School, St. James's Hospital, Wellcome Trust

OpenAlex ID: A5071325331

3D structures of individual mammalian genomes studied by single-cell Hi-C

2017 · Tim J. Stevens, David Lando, et al. · Nature · 826

Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

2020 · Daniel R. Barnes, Matti A. Rookus, et al. · Genetics in Medicine · 138

PDF

Constraint of gene expression by chromatin remodelling protein CHD4 facilitates lineage specification

2015 · Aoife O'Shaughnessy-Kirwan, Jason Signolet, et al. · Development · 71

The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

2021 · Inge M.M. Lakeman, Alexandra J. van den Broek, et al. · Genetics in Medicine · 37

PDF

391eP National prevalence and spectrum of germline BRCA1/2 pathogenic variants in breast cancer in Ireland

2026 · R.E. Dillon, C.S. McNevin, et al. · ESMO Open

PDF

Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

2020 · Daniel R. Barnes, Matti A. Rookus, et al. · Newcastle University ePrints (Newcastle Univesity)

Works count: 11

Citation count: 1,210

H-index: 5

I10-index: 5